RE-BVS – Piemonte Repository

Sfoglia per AUTORE
SILLER-MATULA JM
Collezione AOU Novara

Items : 5

Thrombosis and fibrinolysis in atherosclerotic cardiovascular disease: it takes two to tango. in European heart journal / Eur Heart J. 2022 Mar 7;43(10):982-984. doi: 10.1093/eurheartj/ehab710.

2022
AOU Novara

Fedorowski A; Siller-Matula JM; Patti G;

Low-dose ticagrelor with or without acetylsalicylic acid in patients with acute coronary syndrome: Rationale and design of the ELECTRA-SIRIO 2 trial. in Cardiology journal / Cardiol J. 2022;29(1):148-153. doi: 10.5603/CJ.a2021.0118. Epub 2021 Oct 8.

2022
AOU Novara

Kubica J; Adamski P; Gorog DA; Kubica A; Jilma B; Budaj A; Siller-Matula JM; Gurbel PA; Alexopoulos D; Badarien? J; D?browski P; Dudek D; Giannitsis E; Horszczaruk G; Jaguszewski MJ; James S; Jeong YH; Kryjak M; Niezgoda P; Ostrowska M; Patti G; Romanek J; Di Somma S; Specchia G; Tantry U; G?sior M; Tyci?ska A; Wojakowski W; Buszko K; et alii...

Reclassification, Thromboembolic, and Major Bleeding Outcomes Using Different Estimates of Renal Function in Anticoagulated Patients With Atrial Fibrillation: Insights From the PREFER-in-AF and PREFER-in-AF Prolongation Registries. in Circulation. Cardiovascular quality and outcomes / Circ Cardiovasc Qual Outcomes. 2021 Jun;14(6):e006852. doi: 10.1161/CIRCOUTCOMES.120.006852. Epub 20

2021
AOU Novara

Rohla M; Pecen L; Cemin R; Patti G; Siller-Matula JM; Schnabel RB; Huber K; Kirchhof P; De Caterina R;

Antithrombotic management and outcomes of patients with atrial fibrillation treated with NOACs early at the time of market introduction: Main results from the PREFER in AF Prolongation Registry. in Internal and emergency medicine / Intern Emerg Med. 2021 Apr;16(3):591-599. doi: 10.1007/s11739-020-02442-9. Epub 2020 Sep 21.

2021
AOU Novara

Darius H; Zamorano JL; Brüggenjürgen B; Verheugt FWA; Huber K; Lucerna M; Rohla M; Sellal JM; Wachter R; Schnabel RB; Siller-Matula JM; Kotecha D; Ricci F; Patti G; Pecen L; Renda G; Duytschaever M; Le Heuzey JY; Schilling RJ; Kirchhof P; De Caterina R;

Non-Vitamin K Oral Anticoagulants (NOAC) Versus Vitamin K Antagonists (VKA) for Atrial Fibrillation with Elective or Urgent Percutaneous Coronary Intervention: A Meta-Analysis with a Particular Focus on Combination Type. in Journal of clinical medicine / J Clin Med. 2020 Apr 14;9(4):1120. doi: 10.3390/jcm9041120.

2020
AOU Novara

Eyileten C; Postula M; Jakubik D; Toma A; Mirowska-Guzel D; Patti G; Renda G; Siller-Matula JM;